
markets
Moderna Raises 2026 Revenue Outlook as Newer Vaccines Gain Traction
Moderna has upgraded its 2026 revenue outlook to projected growth of 15% to 25%, significantly higher than its previous guidance of up to 10%. The biotech…
2 min readvia CNBC Markets
